Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Ducts, lobules and the terminal duct lobular unit, Nottingham Prognostic Index (NPI), and PREDICT, Mastectomy, Ribociclib and the tag breast.
Shares Phyllodes tumour of the breast, CDK4/6, Rare and paediatric cancers without markets and the tag rare.
Shares Abemaciclib, CDK4/6, Estrogen receptor (ERα), CDK4/6 inhibitors and the tag breast.
Shares CDK4/6, Palbociclib, Estrogen receptor (ERα), CDK4/6 inhibitors and the tag breast.
Shares Tamoxifen, Estrogen receptor (ERα), Endocrine therapy (SERMs, AIs, SERDs), Breast cancer (all types) and the tag breast.
Shares PARP, PARP inhibitors, Olaparib, BRCA1 / BRCA2 (HRD) and the tag breast.
Shares Ribociclib, CDK4/6, CDK4/6 inhibitors, HR-positive / HER2-negative breast cancer and the tag breast.
Shares How ER and PR are scored on a breast report (Allred score, H score, and why PR is not a UK core item), Breast cancer (all types), Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tag breast.
The same record for scripts and assistants; checked 2026-09-10. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.